Advancing excellence in laboratory medicine for better healthcare worldwide
All news

Register to the IFCC Webinar on 8 September: Evidence-based Laboratory Medicine

Published: Wednesday, September 1, 2021

8th September 2021
Don't miss the next IFCC webinar!

Registration is complimentary!

Click here to register

Dear Colleagues,

The next IFCC webinar "Evidence-based Laboratory Medicine"  will be held on 8 September 2021.

It has been stated that the laboratory assists in 60-70% of all clinical decisions, e.g. admission, discharge, and drug therapy. The goal of the laboratory is to provide information that is useful in clinical decision-making and to prevent cases where incorrect interpretation leads to poor patient outcomes.

Evidence-based medicine (EBM) has been described as the “conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients”. It involves the integration of best research evidence with clinical expertise and patient values. Evidence-based laboratory medicine (EBLM) focuses on the evaluation and use of laboratory tests to improve patient outcomes. It assists clinical management by integrating the best available research evidence for the use of laboratory investigations with the physician’s clinical expertise and the needs, expectations, and concerns of patients. This leads to improved care and outcomes of individual patients and the effective use of healthcare resources. Evidence-based guidelines are developed using the best evidence to develop statements that guide decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare.

In this webinar, we will cover the basic concepts of EBLM and the “5A’s” involved in obtaining this evidence. Then we will discuss how guidelines are implemented using the best available evidence. And finally, we will look at the evidence to see whether the point of care testing confers any advantage in clinical decision-making in different scenarios.

  • Introduction to EBLM (Dr. Seema Bhargava – India)
  • Guideline Implementation (Dr. Andrew Don-Wauchope – Canada)
  • Point of Care Testing and EBLM (Dr. Katrina Rodríguez-Capote – Canada)

Chair: Prof. Annelise Zemlin (South Africa)

Please feel free to share this event on your social media with #IFCCwebinar

  • Schedule: 20 min per speaker plus 20 min panel discussion
  • Time Zones for 8 September: Live presentations starting at: 10:00AM EDT - 11:00AM Buenos Aires- AR; 4:00PM European Time; 7:30PM India; 10:00PM CST-Beijing
    Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. Click here to convert to your time zone.

Recorded webinar: available on demand

Certificate of Participation: available for all registrants

The IFCC Live Webinar Series is partially sponsored by Siemens and Boston Children's Hospital

 

    

 
Website developed by Insoft